Stigma-Free Sensitive Symptom Intake Module
A private intake form that lets patients report embarrassing symptoms in plain language before seeing a doctor.
A pre-visit intake module, licensable to existing patient-intake platforms, that privately collects embarrassing symptoms (GI, skin, urinary, sexual) using normalized plain-language prompts and hands the clinician a structured summary — so stigma never censors the diagnostic record.
Concept
A licensable pre-visit intake module, built to drop into existing patient-intake platforms, that handles the symptoms patients most often hide from clinicians: GI complaints (gas, belching, incontinence), skin eruptions, urinary and sexual symptoms. Before the appointment, the patient completes a normalized, plain-language sensitive-symptom set privately on their own device — framing such symptoms as common and clinically important rather than shameful — and the clinician receives a structured summary in the chart. The single wedge: eliminate stigma-driven censoring at the point of disclosure so the record is complete from the first visit. It is an intake feature, not a diagnostic or treatment tool.
Why now
The new paper [0] quantifies the cost of censoring stigmatized symptoms in the most literal way: the subject's own candid records of "boils, flatulence, vomiting, and belching" were judged "too unseemly" and cut from the nineteenth-century published editions, and were only restored in a 1958 edition — meaning the complete symptom picture needed for later diagnostic reasoning was suppressed for roughly seventy years. Older paper [4] argues from psychosomatics documentation that clinical knowledge must be ethically informed: respecting personal integrity and boundaries in how sensitive information is elicited changes what patients disclose about their lived bodies. Together they justify a concrete, buildable feature — private, consented, normalized collection of stigmatized symptoms, delivered as structured data — rather than a vague anti-stigma campaign.
Written by GLM · 3 Oct 2026
AI assessment
A focused B2B integration for patient intake that solves a specific clinical data gap (stigma-driven censoring) with a low-friction, licensable module.
- Evidence strength 2/5
- The idea relies on a historical anecdote about Charles Darwin's edited autobiography and a theoretical paper on medical epistemology, which provides a philosophical justification but no empirical data on modern patient disclosure rates.
- Market pull 4/5
- Specialty clinics (GI, Urology) and intake platforms like Phreesia have a clear incentive to capture more accurate patient data to improve diagnostic speed and billing.
- Novelty & moat 3/5
- While symptom trackers exist (e.g., Odyssey Diary), the specific focus on 'stigma-reduction' as a mechanism for data completeness in a B2B intake context is a distinct angle.
- Feasibility 5/5
- The product is a structured digital form with a specific UX/copywriting layer, making it extremely easy to build and demo as a prototype.
- Wedge clarity 5/5
- The wedge is sharp and specific: a licensable module for sensitive symptom intake that integrates into existing workflows.
- Simplicity / focus 5/5
- The idea avoids 'platform creep' and focuses on a single, well-defined feature: the intake of stigmatized symptoms.
Scored by Gemma 4 · 3 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
- Oshi Healthcompany
Oshi delivers virtual GI care where gas, belching, and bowel symptoms — exactly the symptoms censored from the historical record in the new paper — are core complaints; normalized pre-visit disclosure improves its intake quality.
- Phreesiacompany
Phreesia's patient-intake platform is the natural distribution channel; a sensitive-symptom module is a direct feature extension that improves data completeness for its health-system clients.
IFFGD educates patients who routinely underreport embarrassing GI symptoms; a disclosure tool advances its mission and could be distributed through its patient channels.
- Rome Foundationorganization
Its functional GI disorder criteria depend entirely on patient symptom reporting; stigma-free disclosure directly improves the data quality behind its diagnostic criteria.
Research it builds on
- Autobiography of Charles Darwin, 1809–1882. With Original Omissions RestoredCharles Robert Darwin · 2026 · 252 citationsAll ideas from this paper →
- The lived body as a medical topic: an argument for an ethically informed epistemologyAnna Luise Kirkengen, Eline Thornquist · 2012 · 38 citationsAll ideas from this paper →